155 results on '"Poreba M"'
Search Results
2. Modification of the Cu-ETP copper surface layer with chromium by physical vapor deposition (PvD) and diffusion annealing
3. Radiological cardiothoracic ratio as a potential predictor of right ventricular enlargement in patients with suspected pulmonary embolism due to COVID-19
4. Quality of a Copper-Phosphorus Alloy
5. Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates
6. The volume of the carotid bodies and blood pressure variability and pulse pressure in patients with essential hypertension
7. PREFACE: THE 2021 EDITION OF THE XXIVTH ISPRS CONGRESS
8. Biochemical characterization of autophagin-2 from the parasite Trypanosoma cruzi: P20-22
9. PREFACE: THE 2020 EDITION OF THE XXIVTH ISPRS CONGRESS
10. P2532Association of serum phospholipid cis-palmitoleic acid with diabetes duration, systemic inflammation and circulating oxLDL in type 2 diabetic patients with atherosclerotic cardiovascular disease
11. Percutaneous coronary intervention causes prolonged c-reactive protein increase in patients with stable coronary artery disease
12. X-ray crystal structure and specificity of the plasmodium falciparum malaria aminopeptidase PfM18AAP
13. Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum
14. Caspase Substrates and Inhibitors
15. Current Strategies for Probing Substrate Specificity of Proteases
16. Role of fatty acid transport protein 4 in oleic acid-induced glucagon-like peptide-1 secretion from murine intestinal L cells
17. ARTERIAL BLOOD PRESSURE AND HEART RATE VARIABILITY IN PERSONS AFTER SMOKING CESSATION
18. KNOWLEDGE ON THE CAUSES AND COMPLICATIONS OF ARTERIAL HYPERTENSION IN RANDOMLY SELECTED STUDENTS FROM POLISH CITIES
19. OCCUPATIONAL EXPOSURE TO LEAD AND SERUM CYSTATIN C CONCENTRATION IN PATIENTS WITH ARTERIAL HYPERTENSION
20. CARDIOVASCULAR DAMAGES IN PATIENTS WITH ARTERIAL HYPERTENSION CHRONICALLY EXPOSED TO LEAD AND RELATIONS TO BLOOD PRESSURE VARIABILITY: PP.25.25
21. THE EFFICACY OF HYPOTENSIVE THERAPY AND COMPLIANCE IN INHABITANTS OF THE CITY OF WROCLAW WITH ARTERIAL HYPERTENSION: PP.20.293
22. THE INFLUENCE OF TYPE 2 DIABETES CO-EXISTENCE ON HEART RATE VARIABILITY IN PATIENTS WITH ARTERIAL HYPERTENSION: PP.17.163
23. The profile of health locus of control in parents of type 1 diabetic children.
24. Current Strategies for Probing Substrate Specificity of Proteases
25. SNP rs198389 (T-381 C) polymorphism in the B-type natriuretic peptide gene promoter in patients with atherosclerotic renovascular hypertension
26. Expression of CD105 antigen in patients with acute leukemia, malignant lymphoma, and multiple myeloma in active phase of the disease
27. The impact of rehabilitation carried out using the Masgutova Neurosensorimotor Reflex integration method in children with cerebral palsy on the results of brain stem auditory potential examinations
28. Hypertrophic cardiomyopathy in a 52-year-old man suspected of a coronary disease - Description of the case
29. The concentration of asymmetric dimethylarginine (ADMA) in serum in active smokers,Stez•enie asymetrycznej dimetyloargininy (ADMA) w surowicy krwi czynnych palaczy papierosów
30. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma
31. Caspase-2 is essential for proliferation and self-renewal of nucleophosmin-mutated acute myeloid leukemia.
32. Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin.
33. CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.
34. Thermoprotection by a cell membrane-localized metacaspase in a green alga.
35. Resurrection of an ancient inflammatory locus reveals switch to caspase-1 specificity on a caspase-4 scaffold.
36. Engineering caspase 7 as an affinity reagent to capture proteolytic products.
37. Multiplexed Probing of Proteolytic Enzymes Using Mass Cytometry-Compatible Activity-Based Probes.
38. Extended subsite profiling of the pyroptosis effector protein gasdermin D reveals a region recognized by inflammatory caspase-11.
39. Protease-activated prodrugs: strategies, challenges, and future directions.
40. Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages.
41. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
42. Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells.
43. Recent advances in the development of legumain-selective chemical probes and peptide prodrugs.
44. Characterization of P. falciparum dipeptidyl aminopeptidase 3 specificity identifies differences in amino acid preferences between peptide-based substrates and covalent inhibitors.
45. Fluorescent activity-based probe for the selective detection of Factor VII activating protease (FSAP) in human plasma.
46. Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples.
47. Caspase selective reagents for diagnosing apoptotic mechanisms.
48. Development of an advanced nanoformulation for the intracellular delivery of a caspase-3 selective activity-based probe.
49. Extensive peptide and natural protein substrate screens reveal that mouse caspase-11 has much narrower substrate specificity than caspase-1.
50. Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.